glp 1 meds for addiction IUPHAR review – Glucagon-like peptide-1 (GLP-1) and substance use disorders: An emerging pharmacotherapeutic target IUPHAR review – Glucagon-like peptide-1

For best results, take consistently

Research shows that once the medication is stopped, weight regain is common, often rapid, because the underlying drivers remain untouched (Quarenghi et al

Reduces nausea, fatigue, and constipation Preserves mus

These medications can be extremely effective when paired with the right care model, so they can be life-changing for patients

However, because glucagon-like peptide-1 receptor agonists work to slow gastric emptying, a safety concern has been raised in patients undergoing deep sedation or general anesthesia regarding gastric aspiration, and considering their long half-life in the blood, they are difficult to manage in the perioperative period

So, it's infuriating to get ads like this